SGEM#120: One Thing or Two for Community Acquired Pneumonia?

Ensaios extraídos do podcast de Dr. Ken Milne

• 2014β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired PneumoniaInfection & AntimicrobialsIn 580 adults hospitalised with moderately severe pneumonia, beta-lactam monotherapy delayed clinical stability at day 7 versus beta-lactam plus macrolide.
• 2015CAP-STARTInfection & AntimicrobialsIn 2283 adults admitted with community-acquired pneumonia, beta-lactam monotherapy was non-inferior to beta-lactam–macrolide or fluoroquinolone for 90-day mortality